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Introduction
etal phosphides are potent, extremely toxic and highly effective insecticides and rodenticides. They are commercially used for protection of crops during storage, as well as during transportation. For many years, metal phosphides have major merits of being highly potent against broad spectrum of insect species, inexpensive, not affecting seed viability and leave little residues on food grains. Yet, they elicit extreme human toxic effects without available suitable antidote. Phosphides poisoning is a commonly encountered poisoning in emergency departments in most developing countries (Proudfoot, 2009; Bumbrah et al., 2012; Nagy et al., 2015) .
Phosphides are found as powders or pellets, usually in the form of zink or aluminum or calcium and magnesium phosphide. Owing to increased agricultural and nonagricultural use, easy availability in markets as well as low price, phosphide is emerging as a common self-poisoning agent, with increasing number of cases in the past four decades. On the other hand, exposure is uncommonly accidental and rarely homicidal (El-Naggar and El-Mahdy, 2011; Singh et al., 2014) .
M
Acute phosphides poisoning is due to either direct salt ingestion or indirect inhalation of phosphine gas generated during approved use. Several mechanisms have been described for phosphides toxicity. Cellular damage and cardio-respiratory failure are the most common mechanisms of mortality and morbidity after poisoning (Proudfoot, 2009; Moghaddam et al., 2015) .
According to Bumbrah et al., (2012) , cytotoxic phosphine gas generated due to acid hydrolysis of metal phosphides affects heart, lungs, kidneys and gastrointestinal tract. Metal phosphides toxicity causes nausea, restlessness, abdominal pain, palpitation, pulmonary edema, cyanosis, hypotension, shock and cardiac arrhythmias. Other rare effects include hepatitis, acute tubular necrosis, disseminated intravascular coagulation and respiratory alkalosis. Their detrimental effects have been described by several authors over a long period of time. However, central nervous system intoxication has been described once by Guale et al. (1994) .
Over the past 20 years, biochemical markers of brain damage have been increasingly studied as potential tools for prognostic evaluation (Kovesdi et al., 2010) . S-100β protein is the β-subunit of a calcium binding protein present mainly in glial and Schwann cells (Zimmer et al., 1995) . Its concentrations increase in human blood and cerebrospinal fluid after a wide range of diseases or conditions leading to brain damage . Despite growing evidence suggesting a potential clinical role for S-100β as a biomarker, its measurements are not widely used in clinical practice and are not considered standard of care (Kovesdi et al., 2010) . Therefore, the current study aimed to evaluate central nervous system affection by phosphides through estimation of serum S-100β protein concentrations, and to investigate the prognostic value of serum S-100β protein as a mortality predictor after acute phosphides intoxication.
Patients & methods
This prospective observational cross sectional study was carried out following approval of research ethical committee of Tanta Faculty of Medicine. Patients admitted to Poison Control Unit (Emergency Hospital, Tanta University) suffering from acute phosphide poisoning in nine month period from the 1 st of November 2014 to 31 st of August 2015 was included in this study. Written informed consent was obtained from each patient or his/her guardians (if the patient was unable to participate in the consent process). Confidentiality of the data will be maintained by making code numbers (available to investigators only) for each patient. All the data were analyzed anonymously.
Eligibility criteria
Male or female patients, more than 15 years old (to increase the sample size) with acute phosphide poisoning (deliberate or accidental) were included in the study. The diagnosis was made on the basis of typical clinical manifestations together with reliable identification of the compound based on container brought by patient attendants. Subsequent confirmation was performed through silver nitrate test for phosphine detection in gastric contents.
Patients less than 15 years, patients exposed to other substances in addition to phosphide, patients with medical conditions (e.g. cardiovascular disease, renal or hepatic failure) were excluded. Similarly, patients presenting more than 12 hours of having phosphide compound (late presenters) and patients treated for acute phosphide poisoning in any medical center before admission were excluded. Interventions For all patients sociodemographic data (age, occupation, education, residence and marital state) and poisoning data (route & circumstances of poisoning and prehospitalization period) were explored.
Clinical examination included vital signs (pulse, blood pressure, temperature and respiratory rate), neurological examination and level of consciousness (Glasgow Coma Scale, GCS) were done for every patient. Moreover, respiratory system, cardiovascular system, GIT and urinary system were evaluated for each of the participants. Blood pressure was continuously monitored and the lowest reading was recorded. Glasgow Coma Scale was assessed every four hours and with any change in conscious level, the lowest reading was recorded.
Blood samples were collected immediately after admission before administration of any medication under complete aseptic conditions. One milliliter venous blood was kept into a clean dry centrifuge tube and left to stand for few hours before centrifugation to avoid hemolysis. After sampling, the blood was centrifuged for 15 min at 1500g, and the serum was separated. It was stored and deep frozen at -80 o C until analysis of S-100β protein level. The serum S-100β protein levels were measured by enzyme-linked immunosorbent assay with commercially available kits (BioVendor Laboratory Medicine, Inc., Modrice, Czech Republic) in a TECAN Sunrise absorbance reader.
Outcome measures
Primary outcome included mortality. Meanwhile, secondary outcomes included GCS, hypotension and length of hospital stay.
Methods of Statistical analysis
All statistical calculations were made using the Statistical Package for the Social Sciences for Windows version 21.0 software program. Data were analyzed with the Kolmogorov-Smirnov test for normality. Values were reported as median (minimum-maximum) for data that were not distributed normally. A value of p < 0.05 was accepted as statistically significant.
To compare the groups, Mann-Whitney U test were used. Analysis of variables within categories was done with the Chi-square, Fisher's exact tests and Monte Carlo correction. Correlation analysis was performed with the Kendall's tau-b ( ) test. Receiver-operating characteristic curves for predicting mortality were generated from the data. Sensitivity and specificity were also calculated for S100B levels using Medcalc software. Results A total of 29 patients poisoned by phosphides have participated in the study. Their median age was 20 years; range 15-50 years; of them 19 females, 10 males. Sociodemographic characteristics of the participant patients were illustrated in table (1). There was no statistical significant difference between survivor patients and non-survivor patients considering age, gender and residence.
Table (2) indicated clinical data of the participant patients, GCS ranged between 6.0-15.0 (13.621±2.36) with a median of 14.000. Mean arterial blood pressure fluctuated between 33.33-110.00 (82.87±20.15), its median value was 90.00. There was statistical significant difference between survivor patients and non-survivor patients regarding systolic blood pressure, diastolic blood pressure and mean arterial blood pressure. Meanwhile, no statistical significant difference was noticed between survivor patients and non-survivor patients in either GCS or pulse rate or duration of hospital stay; p=0.077, 0.095 and 0.167 respectively.
Toxicological data of the participant patients are demonstrated in table (3). It revealed that, 28 (96.6%) of patients were in suicidal attempts, while, only one patient (3.4%) was accidental exposure. Similarly, oral route was registered in 28 (96.6%) of cases and inhalation route represented one (3.4%) of cases. Zink phosphide was identified in 22 (75.9%) of patients, while, aluminum phosphide was recognized in 7 (24.1%) patients. Pre hospital period ranged between 0.5-12 hours with a mean value of 3.293±2.78 and a median 2.000 hours. Statistical significant difference could be detected between survivor patients and non-survivor patients in both phosphide type and pre hospital period.
Serum level of S-100β concentrations recorded values between 0.710-2.656 µg/L (1.452±0.548) with a median 1.242. It was significantly increased in phosphide intoxicated patients compared to the reference value for detection of injury to neural tissue (0.1 µg/L); p < 0.05. Moreover, it registered statistical significant difference between survivor patients and non-survivor patients; p=0.000 as shown in table (3). Table ( 4) revealed negative statistical correlation between serum S100β concentrations and GCS, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure and positive statistical correlation with the length of hospital stay. However, such correlation was significant only with GCS (p=0.003).
Analysis of receiver operating characteristics (ROC) curve of serum S-100β level as a predictor of mortality ( Figure 1 ) showed an area under the curve (AUC) = 0.956, with a 95.6% confidence interval (80.7% -99.8%), P <0.0001*. At a cut off value > 1.762 ug/l, serum S100β had a sensitivity of 100% (were able to predict all cases that died) and a specificity 95% (Table  5) . Moreover, positive predictive value (PPV) has been calculated and was 95%, while negative predictive value (NPV) was 100%. 
Discussion
Metal phosphides, including aluminum and zinc phosphide, are used throughout the world as pesticides to protect stored grains from rodents and other pests. It liberates toxic phosphine gas following contact with water, moisture in the air, or hydrochloric acid in the stomach (Shadnia et al., 2005) . Phosphides (aluminum and zinc) poisoning are commonly used to commit suicide in Egypt and developing countries due to its low price and easy availability (Lall et al., 1997 , Hsu et al., 2002 El Naggar & El Mahdy, 2011) .
The current study aimed to evaluate central nervous system affection by phosphides through estimation of serum S-100β protein concentrations, and to investigate the prognostic value of serum S-100β protein as a mortality predictor after acute phosphides intoxication.
The results of the present study showed that the mean age, gender, residence, route and mode of poisoning were more or less in agreement with findings in majority of centers in Egypt and across the world (Schmidtke et al., 1996; Hawton et al., 1999; Hulten et al., 2000; Kapoor et al., 2006; El Naggar & El Mahdy, 2011; Hosseinian et al., 2011; Khurana et al., 2011; Vijayanath et al., 2011; Soltaninejad et al., 2012) .
Zinc phosphide represented 75.9% of cases in the current study, while aluminum phosphide represented 24.1% of cases. However, there was a significant statistical difference between survivors and non survivors in both aluminum and zinc phosphide intoxicated patients. Where, all aluminum phosphide cases have died and only two cases of zink phosphide have died.
Such high death rate in aluminum phosphide could be explained in light of rapid release of highly toxic phosphine gas by action of dilute hydrochloric acid content of the stomach. It blocks cytochrome C oxidase enzyme, hence, mitochondrial oxidative phosphorylation is inhibited. In addition, it disturbs mitochondrial morphology, inhibits oxidative respiration by 70% and causes severe drop in mitochondrial membrane potential, causing, in turn, the cells to die rapidly (Bumbrah et al., 2012) .
On the other hand, zinc phosphide is slower in onset since it releases phosphine gas more slowly than aluminum phosphide (Goel & Aggarwal, 2007) . Ingestion of as little as half a tablet of aluminum phosphide will probably lead to death (aluminum phosphide lethal dose is 0.15 -0.5 g), while, zinc phosphide maximum tolerated dose is 50 g (Stephenson, 1967; Goel & Aggarwal, 2007; Wahab et al., 2008) .
In the present study, pre-hospitalization period ranged from 0.5-12 hours. There was a significant statistical difference between survivors and non survivors regarding pre-hospitalization period. This is consistent with findings of who observed that the duration between exposure and arrival to hospital was 2.8 ± 0.3 hours in survival while cases that died had a longer duration of 4.2 ± 0.7 hours. This could be attributed to rapid generation of phosphine gas which is rapidly absorbed throughout the gastrointestinal tract, reaches the blood stream. Therefore, delay in seeking medical advice might increase morbidity and mortality (Wexler, 2005) . Louriz et al. (2009) found that Glasgow coma scale (GCS) of patients poisoned by phosphides ranged between 8 and 15 which coincide with the results of this study. Where, GCS ranged between 6-15 with no statistical significant difference between survivors and non-survivors. Glasgow coma scale might be an indicant of CNS affection by phosphide intoxication according to Guale et al. (1994) . They described central nervous system intoxication and depression as clinical signs in phosphides poisoning.
The results of the current study recorded median values for systolic, diastolic and mean arterial blood pressure of 120, 70 and 90 mmHg respectively. In addition to statistical significant differences between survivors and non-survivor patients considering systolic, diastolic and mean arterial blood pressure. These findings could be explained in light of data gathered by Chugh et al. (1998) who reported non-recordable blood pressure and shock as the most common manifestations following phosphides ingestion. Furthermore, Rodenberg et al. (1989) advocated that after phosphides ingestion delayed death results from cardiotoxicity due to the absorption of trace amount of phosphide into body.
S-100β is a calcium-binding protein produced and released by astrocytes. It has neurotropic and gliotropic activity, that is important for CNS recovery after various types of injury ). Likewise, S-100β is involved in CNS energy metabolism regulation and many immunological functions (Rothermundt et al., 2003) . Increased S-100β levels are associated with variety of poisonings affecting CNS, such as carbon monoxide poisoning and benzodiazepine overdose (Ambrozic et al., 2008; Cakir et al., 2010) . Based on these reports, significantly elevated serum levels of S-100β in phosphides intoxicated patients, compared to the reference value, is an indication for phosphides induced neural tissue injury.
Such phosphides induced neural injury was previously mentioned once by Guale et al. (1994) . They described central nervous system intoxication as clinical sign in phosphides poisoning. In post-mortem reports; Tripathi and Pandey (2007) reported distinct changes in the cerebral and cerebellar cortex due to the effect of phosphides on human brain. Additionally, observed mild capillary dilation and congestion of cortex, cerebral edema, and cerebellar edema. They also observed degenerated Nissel granule in the cytoplasm and deeply stained degenerated eccentric nucleus in brain cortex and degenerated neuron and infiltration of round cell into the molecular layer in cerebella.
To the best of the authors' knowledge, the current study is the first to investigate the serum levels of S-100β in phosphides poisoned patients. Serum S-100β levels in non-survivors group were significantly higher than in survivors group. These results support that, increased S100B levels are associated with severe phosphides induced neural damage. Besides, such results might spot light on CNS toxicity as a cause of death in phosphides intoxication. A proposal that contrast the usually proposed cause of death in phosphides toxicity which is respiratory and cardiac arrest (Mathiharan and Patnaik, 2008) .
There was a negative correlation between serum S-100β concentrations and GCS, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure and a positive correlation with length of hospital stay. It means that, the lower GCS, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure, the higher S-100β concentrations are and the longer hospital stay, the higher S-100β concentrations are. However, such correlation was significant only with GCS that could be attributed to the small sample size.
Phosphide induced mortality is very high. Thus, predicting its outcome is one of the vital issues. Acute Physiology and Chronic Health Evaluation II (APACHE II) and Simplified Acute Physiology Score II (SAPS II), two of several intensive care units scoring systems, have demonstrated an ability to predict mortality rates in phosphides poisoning (Bumbrah et al., 2012) .
Hajouji Idrissi et al. (2006) found that APACHE II and SAPS II were positively correlated with poor outcome in phosphides poisoning. Louriz et al. (2009) evaluated the predictive power of APACHE II in aluminum phosphide poisoning. Shadnia et al. (2010) concluded that SAPS II calculated within the first 24 h was a good prognostic indicator. Studies have been conducted on the role of a single clinical and/or paraclinical finding in predicting the outcome of acute aluminium phosphide poisoning (Chugh et al., 2000; Shadnia et al., 2009; Mathai et al., 2010) .
Providentially, high S-100β levels might be a predictor for mortality in acute phosphides intoxication. In the present study, it was determined that an S-100β value over the cutoff value > 1.762 ug/l was sensitive and specific in the prediction of mortality, with sensitivity of 100% and a specificity 95%. Moreover, PPV was 95% and NPV was 100%; which means that, above the level of 1.762 ug/l, S-100β could predict death in 95% of patients, and below this level, death could excluded as an outcome in 100% of patients. These data suggest that S100B may be helpful in predicting mortality of phosphides intoxicated patients. However, it will require further researches to investigate and evaluated the predictive power of serum S-100β values as mortality predictor.
Study limitations
Small sample size comprises a major study limitation in this study as larger sample size might reflect statistically significant correlations rather than statistical correlations between serum S-100β and systolic blood pressure, diastolic blood pressure, mean arterial blood pressure and length of hospital stay.
Identification of phosphide type is usually made from the history where, aluminum phosphide is formulated in solid form as tablets or pellets placed in porous bags or blister packs, on the other hand, zinc phosphide is a steel gray crystalline powder.
There was no standard sampling time for S-100β after poisoning event. Nevertheless, it is impossible to control the time interval between poisoning and S-100β sampling because it depends on time between poisoning and patient arrival to ED.
S-100β was measured once on admission. A series of measurements over time may provide more insight into the role of this marker in acute phosphide poisoning.
Conclusion: From the result of the present study, it could be concluded that:
-Phosphide induced CNS damage is an issue that require further investigations to be confirmed using different tools. -S-100β protein as predictor for mortality in phosphide intoxicated patients require further evaluation.
